HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Febrile responses in patients with pediatric rheumatic diseases].

Abstract
Fever is one of the critical symptoms of patients in pediatrics field. It indicates inflammatory focus somewhere in the body, and the major causes of fever are infectious diseases. Recent progresses of our knowledge about autoinflammatory syndrome promoted the investigation of the mechanism of fever, and suggested that the pro-inflammatory cytokines are the direct causative agents of fever. The basic science revealed that cooperation of IL-6 and IL-1β induces febrile response. Fever of unknown origin (FUO) remains a challenging problem. Rheumatic diseases, rare infectious diseases, and benign tumors and malignancies are diagnoses to be differentiated. FDG-PET is recently proved a valuable tool for the identification of the etiology in patients with FUO. Since the introduction of biological response modifiers into the treatment of patients with pediatric rheumatic diseases has shifted the therapeutic paradigm, a new concept that the blockade of a unique pro-inflammatory cytokine brings cessation of whole inflammatory responses affected tremendously the clinical medicine. A more investigation of inflammation and its pathophisiology will be needed in pediatric rheumatology.
AuthorsShumpei Yokota, Masako Kikuchi, Tomo Nozawa, Toshitaka Kizawa, Taichi Kanetaka, Keisuke Kadota, Takako Miyamae, Masaaki Mori
JournalNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology (Nihon Rinsho Meneki Gakkai Kaishi) Vol. 35 Issue 6 Pg. 511-9 ( 2012) ISSN: 1349-7413 [Electronic] Japan
PMID23291486 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Inflammation Mediators
  • Interleukin-1beta
  • Interleukin-6
Topics
  • Animals
  • Child
  • Fever (etiology)
  • Fever of Unknown Origin (etiology)
  • Humans
  • Inflammation (etiology)
  • Inflammation Mediators (physiology)
  • Interleukin-1beta (physiology)
  • Interleukin-6 (physiology)
  • Molecular Targeted Therapy
  • Positron-Emission Tomography
  • Rheumatic Diseases (complications, diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: